PT  - JOURNAL ARTICLE
ED  - ,
TI  - Cephradine
AID  - 10.1136/dtb.11.12.47
DP  - 1973 Jun 08
TA  - Drug and Therapeutics Bulletin
PG  - 47--47
VI  - 11
IP  - 12
4099  - http://dtb.bmj.com/content/11/12/47.short
4100  - http://dtb.bmj.com/content/11/12/47.full
SO  - Drug Ther Bull1973 Jun 08; 11
AB  - Cephradine (Eskacef - SKF; Velosef - Squibb) is a new semi-synthetic cephalosporin for oral use. Like other cephalosporins it is active against both Gram-negative and Gram-positive pathogens, apparently including penicillinase-producing staphylococci (though this has been questioned1). It is advertised as having ‘new striking power’, but from the data provided its spectrum of activity closely resembles that of cephalexin (Ceporex - Glaxo; Keflex - Lilly),2 and the promotional literature on cephradine makes no direct comparison between the two drugs.